欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号DE/V/0269/001
药品名称Salmovac 440
活性成分
    • salmonella enteritidis 100000000.0 CFU/ml
剂型Lyophilisate for use in drinking water
上市许可持有人IDT Biologika GmbH Am Pharmapark, 06861 Dessau-Rosslau Germany
参考成员国 - 产品名称Germany (DE)
Salmovac 440
互认成员国 - 产品名称
    • United Kingdom (Northern Ireland) (XI)
    • Ireland (IE)
    • Spain (ES)
    • Portugal (PT)
    • Poland (PL)
    • Lithuania (LT)
    • Bulgaria (BG)
    • Czechia (CZ)
    • Romania (RO)
    • Slovakia (SK)
    • Slovenia (SI)
许可日期2015/12/17
最近更新日期2021/02/23
药物ATC编码
    • QI01AE01 salmonella
申请类型
  • TypeLevel1:[not specified]
  • TypeLevel2:[not specified]
  • TypeLevel3:Informed consent - art 13(c) Dir 2001/82/EC
  • TypeLevel4:[not specified]
  • TypeLevel5:[not specified]
附件文件下载
    市场状态Positive
    ©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase